Robert Hoepner
Impact in
-
- Multiple Sclerosis Research Studies
- Neurology top 5%
- Peripheral Neuropathies and Disorders
- Long-Term Effects of COVID-19
- Autoimmune Neurological Disorders and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Multiple Sclerosis Research Studies 43
- Oncology 24
- Polyomavirus and related diseases 17
- Co-authors
- Andrew Chan (62 shared papers)Ralf Gold (20 shared papers)Anke Salmen (55 shared papers)Ingo Kleiter (6 shared papers)Carsten Lukas (7 shared papers)Simon Faissner (6 shared papers)Christoph Friedli (20 shared papers)Ilya Ayzenberg (2 shared papers)
- Journals
- Therapeutic Advances in Neurological Disorders (12 papers)Neurology Neuroimmunology & Neuroinflammation (7 papers)European Journal of Neurology (6 papers)Multiple Sclerosis and Related Disorders (5 papers)CNS Neuroscience & Therapeutics (5 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Robert Hoepner
90 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Pathology and Forensic Medicine 488
- Neurology 239
- Oncology 236
- Neurology 60
- Biological Psychiatry 16
Countries citing papers authored by Robert Hoepner
This map shows the geographic impact of Robert Hoepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hoepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hoepner more than expected).
Fields of papers citing papers by Robert Hoepner
This network shows the impact of papers produced by Robert Hoepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hoepner. The network helps show where Robert Hoepner may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Hoepner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 127 | |
| 2 | 2013 | 81 | |
| 3 | 2020 | 68 | |
| 4 | 2016 | 53 | |
| 5 | 2014 | 53 | |
| 6 | 2013 | 47 | |
| 7 | 2015 | 46 | |
| 8 | 2016 | 43 | |
| 9 | 2019 | 41 | |
| 10 | 2019 | 40 | |
| 11 | 2016 | 33 | |
| 12 | 2018 | 26 | |
| 13 | 2022 | 23 | |
| 14 | 2020 | 22 | |
| 15 | 2017 | 21 | |
| 16 | 2016 | 21 | |
| 17 | 2014 | 21 | |
| 18 | 2021 | 20 | |
| 19 | 2012 | 19 | |
| 20 | 2019 | 19 |
About Robert Hoepner
Robert Hoepner is a scholar working on Pathology and Forensic Medicine, Oncology, Neurology, Immunology and Infectious Diseases, having authored 99 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (43 papers), Polyomavirus and related diseases (17 papers), Long-Term Effects of COVID-19 (9 papers), Peripheral Neuropathies and Disorders (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (4 papers), Psychosomatic Disorders and Their Treatments (4 papers) and Full-Duplex Wireless Communications (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (488 citations), Neurology (239 citations), Oncology (236 citations), Neurology (60 citations) and Biological Psychiatry (16 citations). Robert Hoepner has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Andrew Chan, Ralf Gold, Anke Salmen, Ingo Kleiter, Carsten Lukas, Simon Faissner, Christoph Friedli, Ilya Ayzenberg, Kerstin Hellwig and Ortwin Adams. Their work appears in journals such as Therapeutic Advances in Neurological Disorders, Neurology Neuroimmunology & Neuroinflammation, European Journal of Neurology, Multiple Sclerosis and Related Disorders and CNS Neuroscience & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.